These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 3511523)

  • 21. Suitable hollow fibre immunobioreactors for specific ex vivo removal of antibodies and antigens from plasma.
    Larue C; Gueraud V; Rivat C
    Clin Exp Immunol; 1985 Oct; 62(1):217-24. PubMed ID: 3905096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
    Sachais BS; Katz J; Ross J; Rader DJ
    J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of LDL-immunoapheresis on plasma concentrations of vitamin E and carotenoids in patients with familial hypercholesterolemia.
    Cauza E; Jansen M; Resch U; Dunky A; Derfler K; Winklhofer-Roob BM; Kostner K
    J Clin Apher; 2004; 19(4):174-9. PubMed ID: 15597350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects.
    Hoeg JM; Demosky SJ; Schaefer EJ; Starzl TE; Brewer HB
    J Clin Invest; 1984 Feb; 73(2):429-36. PubMed ID: 6321555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of plasmapheresis and the plasmasorption and immunosorption of low-density lipoproteins on the humoral immunity function of patients with hereditary hypercholesterolemia].
    Konovalov GA; Osipov SG; Kushekbaeva AE; Nasonov EL; Kukharchuk VV
    Ter Arkh; 1990; 62(1):39-42. PubMed ID: 2333615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective removal of apolipoprotein B-containing serum lipoproteins from blood plasma.
    Stoffel W; Demant T
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):611-5. PubMed ID: 7017720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adsorption of lipoprotein containing apolipoprotein-B through plasma separation for treatment of familial hypercholesterolemia.
    Odaka M; Kobayashi H; Soeda K; Murotani N; Saito Y; Nishide T; Yoshida S; Tani N; Takata S
    Int J Artif Organs; 1986 Sep; 9(5):343-8. PubMed ID: 3781667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracorporeal LDL elimination with immunoabsorption or heparin precipitation: a comparison in 10 patients.
    Richter WO; Vierneisel K; Schwandt P
    Beitr Infusionsther; 1988; 23():127-31. PubMed ID: 2461762
    [No Abstract]   [Full Text] [Related]  

  • 30. Principles of immunapheresis and specific elimination of plasma components.
    Spaethe R; du Moulin A; Bieber F; Böhm W
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(2):239-51. PubMed ID: 8318616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracorporeal LDL elimination with immunabsorption or heparin precipitation: a comparison in 10 patients.
    Richter WO; Vierneisel K; Schwandt P
    Beitr Infusionsther; 1988; 23():127-31. PubMed ID: 2484766
    [No Abstract]   [Full Text] [Related]  

  • 32. [Development of a technique of immunoadsorption of LDL-cholesterol].
    Regnault V; Rivat C; Schooneman F; Marcillier P; Michaely JP; Didelon J; Stoltz JF; Siadat M
    Ann Med Interne (Paris); 1990; 141(7):604-7. PubMed ID: 2085239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-based immunoadsorption as a therapeutic means.
    du Moulin A; Müller-Derlich J; Bieber F; Richter WO; Frei U; Müller R; Spaethe R
    Blood Purif; 1993; 11(3):145-9. PubMed ID: 8280435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of combined monoclonal antibodies for the immunochemical determination of apolipoproteins A-I and B in human plasma.
    Marcovina S; Catapano AL
    Adv Exp Med Biol; 1987; 210():63-71. PubMed ID: 3109219
    [No Abstract]   [Full Text] [Related]  

  • 35. Familial hypercholesterolemia treated by plasma exchange and immunoadsorption.
    Wingard RL
    ANNA J; 1993 Feb; 20(1):84-5. PubMed ID: 8431030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anaphylactic shock after lipid exchange chromatography in a patient with congenital IgA deficiency].
    Enk AH; Bauerschmitz J; Knop J
    Hautarzt; 1995 Aug; 46(8):573-5. PubMed ID: 7558828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies released from immunoadsorbents: effect of support, activation and elution conditions.
    Ubrich N; Rivat C
    Artif Cells Blood Substit Immobil Biotechnol; 1996 Jan; 24(1):65-75. PubMed ID: 8714720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Removal of plasma lipoproteins from circulating blood with a heparin-agarose column.
    Burgstaler EA; Pineda AA; Ellefson RD
    Mayo Clin Proc; 1980 Mar; 55(3):180-4. PubMed ID: 7354654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Management of hypercholesteremia by extracorporeal immune adsorption].
    Riesen WF; Imhof C; Sturzenegger E; Descoeudres C; Mordasini R; Oetliker OH
    Schweiz Med Wochenschr; 1986 Jan; 116(1):8-11. PubMed ID: 3511523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein changes in familial hypercholesterolemia after extracorporeal immunoadsorption of low density lipoproteins.
    Riesen WF; Jaross W; Descoeudres C; Mordasini R; Koban F; Thulin H; Fisher S; Bergmann S
    Ann Biol Clin (Paris); 1988; 46(10):787-91. PubMed ID: 3232868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.